<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Yu, Yanqin</style></author><author><style face="normal" font="default" size="100%">Wong, Wing Hing</style></author><author><style face="normal" font="default" size="100%">Hu, Yao</style></author><author><style face="normal" font="default" size="100%">Shen, Yirong</style></author><author><style face="normal" font="default" size="100%">Xu, Xiaochun</style></author><author><style face="normal" font="default" size="100%">Lu, Shen</style></author><author><style face="normal" font="default" size="100%">Zhu, Libo</style></author><author><style face="normal" font="default" size="100%">Zhang, Xinmei</style></author><author><style face="normal" font="default" size="100%">Bischoff, Farideh Z</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Translation of miRNA blood-based discovery to molecular testing for clinical diagnosis of endometriosis</style></title><secondary-title><style face="normal" font="default" size="100%">medRxiv</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2025-01-01 00:00:00</style></date></pub-dates></dates><elocation-id><style  face="normal" font="default" size="100%">2025.07.23.25332110</style></elocation-id><doi><style  face="normal" font="default" size="100%">10.1101/2025.07.23.25332110</style></doi><volume><style face="normal" font="default" size="100%"></style></volume><issue><style face="normal" font="default" size="100%"></style></issue><abstract><style  face="normal" font="default" size="100%">Endometriosis is a common yet often underdiagnosed condition, partly due to the lack of reliable diagnostics. This study examines the clinical feasibility of a blood-based, miRNA-driven test to diagnose endometriosis and address the challenges of translating next-generation sequencing (NGS) findings into clinical use. Serum from 20 patients and 20 controls underwent miRNA sequencing to identify diagnostic biomarkers. A machine learning model built on all NGS-based differentially expressed miRNA biomarkers achieved ≥90% accuracy. Validation by qPCR confirmed some but not all findings, underscoring the difficulty of adapting NGS discoveries for routine diagnostics. Nonetheless, serum miRNA biomarkers show strong promise for non-invasive endometriosis detection, with further optimization needed for clinical translation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by internal R&amp;D budget of HerAnova LifesciencesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The participants were enrolled under an approved institutional review board protocol (IRB-20240110-R) at the Womens Hospital of Zhejiang University School of Medicine, with informed consent obtained from all individualsI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes</style></abstract></record></records></xml>